Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Sterile Concepts

This article was originally published in The Gray Sheet

Executive Summary

Sterile Concepts: Accepts Maxxim Medical's most recent offer to merge the two companies through a deal valued at approximately $143.5 mil. Under terms of the agreement, Maxxim will purchase all of the roughly 5.5 mil. outstanding shares of Sterile stock for $20 per share and assume about $33 mil. in long-term debt. Finalization of the agreement is contingent upon acceptance by Sterile shareholders; Maxxim plans to begin a tender offer "on or before June 14," the firm says in a June 10 release. Sterile had rejected three previous offers from Maxxim. The first offer was valued at $118 mil.; the second and third offers were valued at $128 mil. and $135 mil. respectively...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts